QADYNA Trademark

Trademark Overview

On Friday, October 1, 2010, a trademark application was filed for QADYNA with the United States Patent and Trademark Office. The USPTO has given the QADYNA trademark a serial number of 85143129. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 9, 2022. This trademark is owned by FoldRx Pharmaceuticals, Inc.. The QADYNA trademark is filed in the Pharmaceutical Products category with the following description:

Orally administered pharmaceutical preparations available by prescription only, for the treatment of a rare protein misfolding disease, namely, amyloidosis
qadyna

General Information

Serial Number85143129
Word MarkQADYNA
Filing DateFriday, October 1, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 9, 2022
Registration Number4106454
Registration DateTuesday, February 28, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2011

Trademark Statements

Goods and ServicesOrally administered pharmaceutical preparations available by prescription only, for the treatment of a rare protein misfolding disease, namely, amyloidosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 9, 2022
Primary Code005
First Use Anywhere DateWednesday, November 30, 2011
First Use In Commerce DateWednesday, November 30, 2011

Trademark Owner History

Party NameFoldRx Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameFoldRx Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameFoldRx Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Friday, September 9, 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, February 28, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, March 11, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Sunday, March 11, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Sunday, March 11, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 20, 2018TEAS SECTION 8 RECEIVED
Tuesday, February 28, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 28, 2012REGISTERED-PRINCIPAL REGISTER
Thursday, January 26, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 25, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, January 23, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 19, 2012STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 18, 2012USE AMENDMENT FILED
Wednesday, January 18, 2012TEAS STATEMENT OF USE RECEIVED
Friday, September 2, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 1, 2011SOU EXTENSION 1 GRANTED
Tuesday, August 30, 2011SOU EXTENSION 1 FILED
Thursday, September 1, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 30, 2011TEAS EXTENSION RECEIVED
Tuesday, March 8, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 11, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 11, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 11, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2011PUBLISHED FOR OPPOSITION
Friday, December 3, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 3, 2010ASSIGNED TO LIE
Tuesday, November 9, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 8, 2010ASSIGNED TO EXAMINER
Tuesday, October 5, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 5, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

qadyna protein rare misfolding disease amyloidosis namely treatment only pharmaceutical administered